Insight

Reference

·

Primary source

Thailand Longevity-Clinic 3-5 Day Package Average Selling Price

USD 8,000-22,000 per visit (median ~USD 12,500)

As ofFY2026-FY2027 list pricing·Sources4·Primary

Bumrungrad VitalLife Executive Longevity Assessment runs USD 12,000 to 18,000 per 3 to 5 day inbound package; Samitivej Longevity Center programmes price at USD 8,000 to 14,000; BNH and Bangkok Hospital Longevity Center bracket USD 9,500 to 16,000; the upper tier (Bumrungrad VitalLife premium with stem cell and exosome adjunct) reaches USD 22,000. Median visit price clears USD 12,500. Bundled visits typically include full-genome and biological-age panel (USD 1,800 to 2,800 component cost), NAD+ IV protocol (USD 1,200 to 2,200), peptide cycle (USD 800 to 1,500), HBOT block (USD 1,000 to 1,800) and physician oversight (USD 1,500 to 3,000). Add-on therapeutic plasma exchange runs USD 4,500 to 8,500 per session.

Download CSV ↓Compare plans →

Figure in context

Bumrungrad VitalLife Executive Longevity Assessment runs USD 12,000 to 18,000 per 3 to 5 day inbound package; Samitivej Longevity Center programmes price at USD 8,000 to 14,000; BNH and Bangkok Hospital Longevity Center bracket USD 9,500 to 16,000; the upper tier (Bumrungrad VitalLife premium with stem cell and exosome adjunct) reaches USD 22,000. Median visit price clears USD 12,500. Bundled visits typically include full-genome and biological-age panel (USD 1,800 to 2,800 component cost), NAD+ IV protocol (USD 1,200 to 2,200), peptide cycle (USD 800 to 1,500), HBOT block (USD 1,000 to 1,800) and physician oversight (USD 1,500 to 3,000). Add-on therapeutic plasma exchange runs USD 4,500 to 8,500 per session.

Bumrungrad VitalLife Executive Longevity Assessment runs USD 12,000 to 18,000 per 3 to 5 day inbound package; Samitivej Longevity Center programmes price at USD 8,000 to 14,000; BNH and Bangkok Hospital Longevity Center bracket USD 9,500 to 16,000; the upper tier (Bumrungrad VitalLife premium with stem cell and exosome adjunct) reaches USD 22,000. Median visit price clears USD 12,500. Bundled visits typically include full-genome and biological-age panel (USD 1,800 to 2,800 component cost), NAD+ IV protocol (USD 1,200 to 2,200), peptide cycle (USD 800 to 1,500), HBOT block (USD 1,000 to 1,800) and physician oversight (USD 1,500 to 3,000). Add-on therapeutic plasma exchange runs USD 4,500 to 8,500 per session.

Time scope

FY2026-FY2027 list pricing

Source basis

Primary source

Interpretation notes

What this tells you

Bumrungrad VitalLife Executive Longevity Assessment runs USD 12,000 to 18,000 per 3 to 5 day inbound package; Samitivej Longevity Center programmes price at USD 8,000 to 14,000; BNH and Bangkok Hospital Longevity Center bracket USD 9,500 to 16,000; the upper tier (Bumrungrad VitalLife premium with stem cell and exosome adjunct) reaches USD 22,000. Median visit price clears USD 12,500. Bundled visits typically include full-genome and biological-age panel (USD 1,800 to 2,800 component cost), NAD+ IV protocol (USD 1,200 to 2,200), peptide cycle (USD 800 to 1,500), HBOT block (USD 1,000 to 1,800) and physician oversight (USD 1,500 to 3,000). Add-on therapeutic plasma exchange runs USD 4,500 to 8,500 per session.

What not to do with it

Use the linked report for interpretation and keep basis differences explicit.

Related figures

Adjacent numbers that add context without drowning the value.

2027 forecast
USD 0.8-1.5B by 2027 (vs USD 0.18-0.3B 2024)

Thailand Longevity-Medicine Clinic Tourism Market Size

Insight derivation from Bumrungrad Form 56-1 FY2024, BDMS Form 56-1 FY2024, TAT Medical Wellness Strategic Plan 2023-2027, IMARC Global Longevity 2024, retreat resort tariff disclosures

FY2026-FY2027 published tariff
USD 35,000-65,000 per person (Aman Puri premium tops USD 65,000)

Phuket Wellness Resort 14-Day Longevity Retreat Average Selling Price

Banyan Tree Wellbeing Sanctuary tariff 2025, Aman Puri Wellness Immersion brochure 2025, Six Senses Yao Noi wellness menu 2025, Insight derivation

Effective Q1 2027
Compounding-pharmacy registration; off-label-by-protocol clinical use

Thai FDA Clinical Longevity Protocol Framework: Q1 2027 Effect Date

Thai FDA Notification B.E. 2569, Thai Medical Council off-label preventive medicine guideline 2024, MoPH briefing materials

FY2026-FY2027 inbound mix
Hong Kong 22%, Singapore 17%, Middle East 18%, US/AU/EU 28%, Thai domestic 15%

Thailand Longevity-Clinic Inbound Buyer Origin Mix

TCEB Wellness Tourism Report 2026 buyer-profile annex, Bumrungrad Form 56-1 FY2024 international-patient mix disclosure, Insight derivation

FY2024-FY2027 incentive window
0% import duty on HBOT, plasmapheresis, body composition; CIT holiday up to 8 years

BOI Section 8 Medical-Tourism Premium Tier: 0% Duty on Longevity Equipment

Thailand Board of Investment A4 Guide 2024, BOI project approvals 2024-2026, Bumrungrad and BDMS investment disclosures

FY2024-FY2027 cohort build
~50,000 Thai whole-genome records (target 100,000 by end-2027)

Genomics Thailand Cohort: 50,000-Person Whole-Genome Substrate for Clinical Longevity

NSTDA Genomics Thailand Initiative cohort progress report December 2025, Bumrungrad VitalLife genomic-medicine programme materials

Report context

Thailand Anti-Aging & Longevity Clinics 2027 Market Intelligence

Thailand is repositioning premium medical tourism away from cosmetic surgery, IVF and dental toward longevity-medicine clinics: rapamycin and metformin off-label protocols, NAD+ IV infusions, peptide therapeutics (BPC-157, CJC-1295), hyperbaric oxygen, therapeutic plasma exchange, full-genome and biological-age testing, and senolytics. The 2026 to 2027 catalyst stack includes the Bumrungrad VitalLife Wellness flagship, BDMS Bangkok Hospital Longevity Center, Samitivej Sukhumvit Longevity Wing and BNH Wellness Center; the Thai FDA Q1 2027 framework registering compounding pharmacies and off-label-by-protocol clinical use; the BOI Section 8 medical-tourism premium tier covering longevity equipment imports at 0 percent duty; the Phuket Wellness Resort cluster (Banyan Tree, Aman, Six Senses) adding 14-day longevity retreats at USD 35,000 to 65,000; the Genomics Thailand 50,000-person whole-genome cohort; and the cultural mainstreaming via Brian Johnson Blueprint, David Sinclair Tribe and Andrew Huberman. Our read: the 2027 Thai longevity-medicine market reaches USD 0.8 to 1.5 billion (vs USD 0.18 to 0.3 billion in 2024), with Bumrungrad VitalLife, BDMS Longevity, Samitivej, BNH plus the Banyan Tree, Aman and Six Senses retreat resorts capturing roughly 70 percent share, and a long tail of independent boutique wellness clinics taking the remainder.

Open report →

Atlas actors in this figure's reports

Profiles covered in the report that cite this number.

Bangkok Dusit Medical Services

Thailand's largest listed hospital group — 50+ hospitals across six brand families; >THB 110B FY2024 revenue.

Bumrungrad Hospital

Thailand's medical-tourism flagship — first Asian hospital JCI-accredited (2002); >60% international-patient revenue mix.

Thailand Longevity-Clinic 3-5 Day Package Average Selling Price · Insight